SEC Form 4 · accession 0001437749-18-013081
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack B. Strommen
Director
Period of report
Jun 29, 2018
Accepted (ET)
Jul 9, 2018 · 11:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 29, 2018 | C | 7,532 | $0.37 | A | 4,315,544 | I | Securities acquired held through wholly owned single member limited liability company. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.43 | Jun 29, 2018 | A | 34,884 | A | Jun 29, 2018 | Jun 29, 2028 | Common stock | 34,884 | 92,800 | D |
Explanation of responses
- F1This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the three months ended June 30, 2018, pursuant to the Issuer's 2018 Equity Incentive Plan.
- F2Shares were issued as payment of quarterly interest due on a convertible promissory note issued to Reporting Person in Issuer's Spring 2018 Unit Offering. Price per share was calculated using the average closing price of Issuer's common stock for the 20 business days preceding the interest due date.